Apple's new technology patent for flexible folding screen has been approved to prevent glass breakage at the folding area
股海静观陶
发表于 2024-1-10 15:19:28
1259
0
0
Apple's new technology patent for flexible foldable screens has been approved to prevent glass breakage at the folding area. According to a recent list released by the US Trademark and Patent Office, Apple has obtained a technology patent for foldable screens, introducing a chemical method for manufacturing textured glass at the folding area to prevent glass breakage. The patent describes flexible screen technology, which uses a pixel array to form a display panel. After the device is folded, the display panel will bend along the hinge.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Tesla Musk: Expected FSD to be approved and implemented in China before the end of the year
- The Class 1 new drug introduced by Anjin with over 1 billion US dollars has been approved for clinical use
- JD Allianz Equity Transfer Approved: Allianz Insurance Group to Transfer 53.33% Equity of the Company to Allianz China Holdings
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
- Johnson&Johnson's drug Zebaike has been approved in China
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Multiple new indications for Merck drugs approved for market in China
- BeiGene and BeiZeAn are approved for new indications in the United States